Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICU sedation modes after forearm flap reconstruction for oral cancer
ChiCTR-IPR-17013199Phase 4Completed
- Sponsor
- Hospital of Stomatology Wuhan University
- Start
- Jan 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of midazolam, hydromorphone, propofol and dexmedetomidine in mouth cancer (3 arms), sponsored by Hospital of Stomatology Wuhan University. Primary endpoints: Ramsay sedation score, tumor necrosis factor alpha and 1 more. Started Jan 2016; status: completed.
02
Drugs
midazolamhydromorphonepropofoldexmedetomidine
03
Conditions
mouth cancer
Beyond the preview
Go deeper on ChiCTR-IPR-17013199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013199.